- Home
- IMNM vs ARIS Comparison
IMNM vs ARIS Comparison
Compare IMNM & ARIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- ARIS
- Stock Information
- Founded
- IMNM 2006
- ARIS 2015
- Country
- IMNM United States
- ARIS United States
- Employees
- IMNM N/A
- ARIS N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- ARIS Water Supply
- Sector
- IMNM Health Care
- ARIS Utilities
- Exchange
- IMNM Nasdaq
- ARIS Nasdaq
- Market Cap
- IMNM 806.1M
- ARIS 828.1M
- IPO Year
- IMNM 2020
- ARIS 2021
- Fundamental
- Price
- IMNM $6.73
- ARIS $32.05
- Analyst Decision
- IMNM Strong Buy
- ARIS Buy
- Analyst Count
- IMNM 5
- ARIS 6
- Target Price
- IMNM $26.60
- ARIS $27.17
- AVG Volume (30 Days)
- IMNM 1.0M
- ARIS 915.4K
- Earning Date
- IMNM 03-19-2025
- ARIS 05-06-2025
- Dividend Yield
- IMNM N/A
- ARIS 1.75%
- EPS Growth
- IMNM N/A
- ARIS 36.59
- EPS
- IMNM N/A
- ARIS 0.81
- Revenue
- IMNM $9,041,000.00
- ARIS $435,444,000.00
- Revenue This Year
- IMNM N/A
- ARIS $8.98
- Revenue Next Year
- IMNM $476.80
- ARIS $7.68
- P/E Ratio
- IMNM N/A
- ARIS $39.79
- Revenue Growth
- IMNM N/A
- ARIS 11.05
- 52 Week Low
- IMNM $6.41
- ARIS $12.44
- 52 Week High
- IMNM $24.87
- ARIS $33.95
- Technical
- Relative Strength Index (RSI)
- IMNM 29.57
- ARIS 58.11
- Support Level
- IMNM $6.94
- ARIS $30.64
- Resistance Level
- IMNM $7.68
- ARIS $33.95
- Average True Range (ATR)
- IMNM 0.55
- ARIS 1.67
- MACD
- IMNM -0.15
- ARIS 0.12
- Stochastic Oscillator
- IMNM 10.39
- ARIS 63.88
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About ARIS Aris Water Solutions Inc.
Aris Water Solutions Inc is an environmental infrastructure and solutions company that helps customers reduce their water and carbon footprints. It has two primary revenue streams. The Produced Water Handling business gathers, transports, and, unless recycled, handles produced water generated from oil and natural gas production. The Water Solutions business develops and operates recycling facilities to treat, store and recycle produced water.